KSS/KSA/KSI:

KSA, KSS and KSI all represent experimental families of LCP’s currently under development by IC-MedTech. These proprietary molecules and applications involve rationale design of liquid crystal compounds for use at the cellular level. Ongoing research includes products for treatment of a wide range of diseases.